Gecko Bio will help you to plan your product’s journey from discovery to licensure and beyond. Every drug product requires a portfolio of studies and trials to generate the evidence package needed to get you from the bench top to the patient. Translate your pre-clinical findings into a clinical developmoent plan. Plot out the key regulatory and financial milestones. Slot into place the clinical studies you need to generate the evidence package that support the value of your product.
Your two largest capital investments will be clinical trials and manufacture. Gecko Bio will provide you with a bespoke service to plan the development and investment strategy needed to get your drug product to the next step on its journey to becoming a potential medicine, helping you to optimise the size and timing of your clinical and manufacturing investments.
Medical governance
- Design clinical trials
- Biomarker strategy
- Identify outcomes
- Monitor subject safety
- Provide physician oversight
Clinical development
- Find the most efficient route from discovery to licensure
- Sequence indications
- Plan key milestones and decisions
- Create an evidence dossier
Product leadership
- Work cross functionally
- Plan and phase resource
- Navigate operational complexity
Business strategy
- Tell your story
- Identify key value drivers
- Energize partnership discussions
People
Gavin Koh
MB BChir PhD Cantab, FRCP Lond
Gavin Koh is a UK accredited physician with over 10 years of experience in pharmaceutical medicine and drug development extending from phase 1 to phase 3 (and beyond) at GSK and at AstraZeneca. He has had multiple roles as study physician, project physician and product lead and experience in infectious diseases, immuno-inflammation and oncology. Gavin has taken multiple pre-clinical discoveries into first-in-human studies, to proof-of-concept, and to full drug registration globally.
Gecko Bio 